Last reviewed · How we verify
tuberculin for skin test
At a glance
| Generic name | tuberculin for skin test |
|---|---|
| Sponsor | Taichung Veterans General Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Training Protocol on the Natural History of Tuberculosis
- Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB (PHASE2, PHASE3)
- The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis (NA)
- Intralipid® 20% for Reversal of Local Anesthetics (PHASE4)
- Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients
- ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
- A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin Tones (NA)
- Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tuberculin for skin test CI brief — competitive landscape report
- tuberculin for skin test updates RSS · CI watch RSS
- Taichung Veterans General Hospital portfolio CI